Early identification of oral cancer through saliva

A new study suggests that early oral and palate can be diagnosed when microARN levels exceed 50, simpler and less time-consuming than biopsies.

Saliva testing is a simple and quick method.

In a recently published study, researchers said it was possible to quickly test oral, nasopharyngeal cancer with saliva.

When measuring the amount of microARN in saliva of 50 people with cancer-causing scaly epithelial cells and 50 healthy people, the scientists found that when the microARN level exceeds 50, it is possible to develop oral cancer.

MicroARN is an active control molecule and the level of cloned genes. Dr. David T. Wong, a professor at the University of California, Los Angeles School of Dentistry said: 'The oral cavity is a mirror reflecting body health. Many diseases that develop in different parts of the body are expressed in the mouth '.

The findings of this study are published in the journal Clinical Cancer Research. According to Professor Wong, there is still a need to monitor more widely and longer.

Meanwhile, Dr. Jennifer Grandis, professor of Otolaryngology and Pharmacology, University of Pittsburgh School of Medicine, thinks that if cancer is identified through saliva without a biopsy, the substance can be found. Characteristic markings for early detection of cancer through saliva.